Current concepts in body dysmorphic disorder

Archives of Psychiatric Nursing

Volumn 16, Issue 2, 2002, Pages 72-79

  Carroll, Deirdre H ^a   Scahill, Larry ^b   Phillips, Katharine A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AGITATION; BEHAVIOR; BODY DYSMORPHIC DISORDER; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DERMATOLOGY; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; EMOTIONALITY; FATIGUE; HEALTH SERVICE; HOSPITALIZATION; HUMAN; INSOMNIA; MEDICAL ASSESSMENT; MEDICAL LITERATURE; MEDICAL RESEARCH; MOOD DISORDER; NEUROPSYCHOLOGY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PREVALENCE; PSYCHIATRY; QUESTIONNAIRE; REVIEW; RISK FACTOR; SEDATION; SEXUAL BEHAVIOR; SIDE EFFECT; SOCIAL PSYCHOLOGY; STRESS; COGNITIVE THERAPY; DIFFERENTIAL DIAGNOSIS; MULTIMODALITY CANCER THERAPY; NURSING; NURSING ASSESSMENT; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; SOMATOFORM DISORDER;

COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; HUMANS; NURSING ASSESSMENT; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SOMATOFORM DISORDERS;

EID: 0036550109     PISSN: 08839417     EISSN: None     Source Type: Journal    
DOI: 10.1053/apnu.2002.32109     Document Type: Review

References (49)

1. Abbruzzese, M., Bellodi, L., Ferri, S., & Scarone, S. (1995). Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: A neuropsychological study. Brain and Cognition, 27(2), 202-212.
2. Albertini, R. S., & Phillips, K. A. (1999). Thirty-three cases of body dysmorphic disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 38(4), 453-459.
3. rd ed.). Washington, DC: Author.
4. rd ed., revised). Washington, DC: Author.
5. th ed.). Washington, DC: Author.
6. Baxter, L. R., Phelps, M. E., Mazziotta, J. C., Guze, B. H., Schwartz, J. M., & Selin, C. E. (1987). Local cerebral glucose metabolic rates in obsessive-compulsive disorder: A comparison with rates in unipolar depression and in normal controls. Archives of General Psychiatry, 44(3), 211-218.
7. Baxter, L. R., Schwartz, J. M., Bergman, K. S., Szuba, M. P., Guze, B. H., Mazziotta, J. C., Alazraki, A., Selin, C. E., Ferng, H., Munford. P., & Phelps, M. E. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry, 49(9), 681-689.
8. Biby, E. L. (1998). The relationship between body dysmorphic disorder and depression, self-esteem, somatization, and obsessive-compulsive disorder. Journal of Clinical Psychology, 54(4), 489-499.
9. Bienvenu, O. J., Samuels, J. F., Riddle, M. A., Hoehn-Saric, R., Liang, K., Cullen, B. A. M., Grados, M. A., & Nestadt, G. (2000). The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biological Psychiatry, 48(4), 287-293.
10. Bourdon, K. H., Boyd, J. H., Rae, D. S., Burns, B. J., Thompson, J. W., & Locke, B. Z. (1988). Gender differences in phobias: Results of the ECA community survey. Journal of Anxiety Disorders, 2(3), 227-241.
11. Brown, K. W., McGoldrick, T. & Buchanan, R. (1997). Body dysmorphic disorder: Seven cases treated with eye movement desensitization and reprocessing. Behavioural and Cognitive Psychotherapy, 25(2), 203-207.
12. Cameron, O. G., & Hill, E. M. (1989). Women and anxiety. Psychiatric Clinics of North America, 12(1), 175-186.
13. Carroll, D. H., (2000). Prevalence, psychosocial, and clinical characteristics of patients who endorse body dysmorphic disorder symptoms in a general medical setting. Manuscript in preparation.
14. Deckersbach, T., Savage, C.R., Phillips, K.A., Wilhelm, S., Buhlmann, U., Rauch, S.L., Baer, L., & Jenike, M.A. (2000). Characteristics of memory dysfunction in body dysmorphic disorder. Journal of the International Neuropsychological Society, 6(6), 673-681.
15. DeMarco, L. M., Li, L. C., Phillips, K. A., & McElroy, S. L. (1998). Perceived stress in body dysmorphic disorder. Journal of Nervous and Mental Disease, 186(11), 724-726.
16. Faravelli, C., Salvatori, S., Galassi, F., Aiazzi, L., Drei, C., & Cabras, P. (1997). Epidemiology of somatoform disorders: A community survey in Florence. Social Psychiatry and Psychiatric Epidemiology, 32(1), 24-29.
17. Hanes, K.R. (1998). Neuropsychological performance in body dysmorphic disorder. Journal of the International Neuropsychological Society, 4(2), 167-171.
18. Hollander, E., Allen, A., Kwon, J., Aronowitz, B., Schmeidler, J., Wong, C., & Simeon, D. (1999). Clomipramine vs desipramine crossover trial in body dysmorphic disorder: Selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Archives of General Psychiatry, 56(11), 1033-1039.
19. Hollander, E., Cohen, L.J., & Simeon, D. (1993). Body dysmorphic disorder. Psychiatric Annals, 23(1), 359-364.
20. Lazosky, A. J., Rultan, L., & Stanley, M. A. (1993). A meta-analysis of neuropsychological findings in obsessive-compulsive disorder. Journal of Clinical Experimental Neuropsychology, 15, 99.
21. Martinot, J.L., Allillaire, J.F., Mazoyer, B.M., Hantouche, E., Huret, J.D., Legaut-Demane, F., Deslauriers, A.G., Hardy, P., Pappata, S., Baron, J.C., & Syrota, A. (1990). Obsessive-compulsive disorder: A clinical, neuropsycholgical and positron emission tomography study. Acta Psychiatrica Scandinavica, 82(3), 233-242.
22. Mayville, S., Katz, R.C., Gipson, M.T., & Cabral, K. (1999). Assessing the prevalence of body dysmorphic disorder in an ethnically diverse group of adolescents. Journal of Child and Family Studies, 8(3), 357-362.
23. Morselli, E. (1891). Sulla dismorfofobia e sulla tafefobia. Bolletinno Della R Accademia di Genova. 6, 110-119.
24. Perugi, G., Giannotti, D., Di Vaio, S., Frare, F., Saettoni, M., & Cassano, G.B. (1996). Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). International Clinical Psychopharmacology, 11(4), 247-254.
25. Perugi, G., Akiskal, H.S., Giannotti, D., Frare, F., DiVaio, S., & Cassano, G.B. (1997). Gender-related differences in body dysmorphic disorder (dysmorphophobia). Journal of Nervous and Mental Disease, 185(9), 578-582.
26. Phillips, K. A. (1991). Body dysmorphic disorder: The distress of imagined ugliness. American Journal of Psychiatry, 148(9), 1138-1149.
27. Phillips, K. A. (1996a). Body dysmorphic disorder: Diagnosis and treatment of imagined ugliness. Journal of Clinical Psychiatry, 57 (suppl. 8), 61-65.
28. st ed.). New York: Oxford University Press.
29. Phillips K. A. (2000a). Quality of life for patients with body dysmorphic disorder. Journal of Nervous and Mental Disease, 188, 170-175.
30. Phillips K. A. (2000b). Pharmacologic treatment of body dysmorphic disorder: a review of empirical data and a proposed treatment algorithm. Psychiatric Clinics of North America, 7, 59-82.
31. Phillips, K. A., Atala, K. D., & Pope, H. G. Jr. (1995). Diagnostic instruments for body dysmorphic disorder. New research program and abstracts: American Psychiatric Association Annual Meeting. Miami: American Psychiatric Association, 157.
32. Phillips, K. A., & Diaz, S. F. (1997). Gender differences in body dysmorphic disorder. Journal of Nervous and Mental Disease, 185(9), 570-577.
33. Phillips, K. A., Dufresne, Jr., R. G., Wilkel, C. S., & Vittorio, C. C. (2000). Rate of body dysmorphic disorder in dermatology patients. Journal of the American Academy of Dermatology, 42(3), 436-441.
34. Phillips, K.A., Dwight, M.M., & McElroy, S.L. (1998). Efficacy and safety of fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry, 59(4), 165-171.
35. Phillips, K.A., Gunderson, C.G., Mallya, G., McElroy, S.L., & Carter, W. (1998). A comparison study of body dysmorphic disorder and obsessive-compusive disorder. Journal of Clinical Psychiatry, 59(11), 568-575.
36. Phillips, K.A., Nierenberg, A.A., Brendel, G., & Fava, M. (1996). Prevalence and clinical features of body dysmorphic disorder in atypical major depression. Journal of Nervous and Mental Disease, 184(2), 125-129.
37. Rosen, J. C., & Reiter, J. (1996). Development of the body dysmorphic disorder examination. Behaviour Research and Therapy, 34(9), 755-766.
38. Rosen, J.C., Reiter, J., & Orosan, P. (1995). Cognitive-behavioral body image therapy for body dysmorphic disorder. Journal of Consulting and Clinical Psychology, 63(2), 263-269.
39. Sarwer, D.B., Wadden, T.A., Pertschuk, M.J., & Whitaker, L.A. (1998). Body image dissatisfaction and body dysmorphic disorder in 100 cosmetic surgery patients. Plastic and Reconstructive Surgery, 101(6), 1644-1649.
40. Sarwer, D.B., Whitaker, L.A., Pertschuk, M.J., & Wadden, T.A. (1998). Reconstructive surgery patients: An underrecognized problem. Annals of Plastic Surgery, 40(4), 403-407.
41. Sharp, C. W., Clark, S. A., Dunan, J. R., Blackwood, D. H. R., & Shapiro, C. M. (1994). Clinical presentation of anorexia nervosa in males: 24 new cases. International Journal of Eating Disorders, 15(2), 125-134.
42. Simeon, D., Hollander, E., Stein, D. J., Cohen, L., & Aronowitz, B. (1995). Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. American Journal of Psychiatry, 152(8), 1207-1209.
43. Soriano, J.L., O'Sullivan, R.L., Baer, L., Phillips, K.A., McNally, R.J., & Jenike, M.A. (1996). Trichotillomania and self-esteem: a survey of 62 female hair pullers. Journal of Clinical Psychiatry, 57(2), 77-82.
44. Veale, D., Boocock, A., Gournay, K., Dryden, W., Shah, F., Wilson, R., & Walburn, J. (1996). Body dysmorphic disorder: A survey of fifty cases. British Journal of Psychiatry, 169(2), 196-201.
45. Veale, D., Gournay, K., Dryden, W., Boocock, A., Shah, F., Willson, R., & Walburn, J. (1996). Body dysmorphic disorder: A cognitive behavioural model and pilot randomised controlled trial. Behaviour Research and Therapy, 34(9), 717-729.
46. Weissman, M. M., & Klerman, G. L. (1977). Sex differences and the epidemiology of depression. Archives of General Psychiatry, 34(1), 98-111.
47. Wilhelm, S., Otto, M.W., Lohr, B., & Deckersbach, T. (1999). Cognitive behavior group therapy for body dysmorphic disorder: A case series. Behaviour and Research Therapy, 37(1), 71-75.
48. Wilhelm, S., Otto, M. W., Zucker, B. G., & Pollack, M. H. (1997). Prevalence of body dysmorphic disorder in patients with anxiety disorders. Journal of Anxiety Disorders, 11(5), 449-502.
49. Zimmerman, M., & Mattia, J. I. (1998). Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Comprehensive Psychiatry, 39(5), 265-270.